Published in Pediatrics on August 01, 2002
Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, Nigeria. BMC Clin Pharmacol (2009) 2.14
Adverse drug reactions in children--a systematic review. PLoS One (2012) 1.65
Risk factors associated with adverse drug reactions in hospitalised children: international multicentre study. Eur J Clin Pharmacol (2011) 1.22
Comparative epidemiology of hospital-acquired adverse drug reactions in adults and children and their impact on cost and hospital stay--a systematic review. Eur J Clin Pharmacol (2013) 0.97
Monitoring adverse drug reactions in children using community pharmacies: a pilot study. Br J Clin Pharmacol (2005) 0.96
Epidemiology of adverse drug reactions in europe: a review of recent observational studies. Drug Saf (2015) 0.95
Are computerised monitoring systems of value to improve pharmacovigilance in paediatric patients? Eur J Clin Pharmacol (2006) 0.94
Perceived adverse drug reactions among non-institutionalized children and adolescents in Germany. Br J Clin Pharmacol (2010) 0.86
Risk assessment of drug interaction potential and concomitant dosing pattern on targeted toxicities in pediatric cancer patients. AAPS J (2013) 0.86
Adverse drug reactions in hospitalized pediatric patients of Saudi Arabian University Hospital and impact of pharmacovigilance in reporting ADR. Saudi Pharm J (2012) 0.85
Epidemiology and potential risk factors of drug-related problems in Hong Kong paediatric wards. Br J Clin Pharmacol (2014) 0.83
Unplanned medication discontinuation as a potential pharmacovigilance signal: a nested young person cohort study. BMC Pharmacol Toxicol (2014) 0.80
Adverse drug events in hospitalized children at Ethiopian University Hospital: a prospective observational study. BMC Pediatr (2015) 0.80
Adverse drug reactions in hospitalised children in Germany are decreasing: results of a nine year cohort-based comparison. PLoS One (2012) 0.79
Dilemmas of the causality assessment tools in the diagnosis of adverse drug reactions. Saudi Pharm J (2015) 0.78
Hepatotoxicity induced by trimethoprim-sulfamethoxazole in a child with cystic fibrosis. J Pediatr Pharmacol Ther (2014) 0.75
Self-reported sulphonamide hypersensitivity reactions in adults living in Ibadan, Nigeria: A cross-sectional, community-based study. Niger Med J (2016) 0.75
Incidence and determinants of medication errors and adverse drug events among hospitalized children in West Ethiopia. BMC Pediatr (2016) 0.75
A CASE REPORT OF SUSPECTED ANGIOEDEMA IN A CHILD AFTER ADMINISTRATION OF MEBENDAZOLE, COTRIMOXAZOLE AND LEAF EXTRACTS. Ann Ib Postgrad Med (2016) 0.75
A pilot study to evaluate a community pharmacy-based monitoring system to identify adverse drug reactions associated with paediatric medicines use. Eur J Clin Pharmacol (2010) 0.75
Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med (2006) 4.74
Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. J Hypertens (2009) 3.13
The Virtual Family--development of surface-based anatomical models of two adults and two children for dosimetric simulations. Phys Med Biol (2009) 3.05
Cyclosporin A is superior to cyclophosphamide in children with steroid-resistant nephrotic syndrome-a randomized controlled multicentre trial by the Arbeitsgemeinschaft für Pädiatrische Nephrologie. Pediatr Nephrol (2008) 2.92
Human laminin beta2 deficiency causes congenital nephrosis with mesangial sclerosis and distinct eye abnormalities. Hum Mol Genet (2004) 2.67
A genome-wide Drosophila screen for heat nociception identifies α2δ3 as an evolutionarily conserved pain gene. Cell (2010) 2.37
Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy. Kidney Int (2011) 2.34
Reversal of pathological pain through specific spinal GABAA receptor subtypes. Nature (2008) 2.30
Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man. FASEB J (2007) 2.00
Blockade of TNF-α rapidly inhibits pain responses in the central nervous system. Proc Natl Acad Sci U S A (2011) 1.95
Drug use in children: cohort study in three European countries. BMJ (2008) 1.91
Syncytin, a novel human endogenous retroviral gene in human placenta: evidence for its dysregulation in preeclampsia and HELLP syndrome. Am J Obstet Gynecol (2002) 1.84
The S. Typhimurium effector SopE induces caspase-1 activation in stromal cells to initiate gut inflammation. Cell Host Microbe (2009) 1.74
Preanalytical influences on the measurement of ghrelin. Clin Chem (2002) 1.57
The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients. Drug Saf (2004) 1.57
Compliance with recommended immunizations in adolescents. Eur J Pediatr (2006) 1.45
Cyclooxygenase-2--10 years later. J Pharmacol Exp Ther (2002) 1.44
Intrauterine growth restriction leads to a dysregulation of Wilms' tumour supressor gene 1 (WT1) and to early podocyte alterations. Nephrol Dial Transplant (2012) 1.44
Engineering of vascularized transplantable bone tissues: induction of axial vascularization in an osteoconductive matrix using an arteriovenous loop. Tissue Eng (2006) 1.40
Prolonged lifespan by defective insulin signalling? Eur J Endocrinol (2003) 1.39
Change of the course of steroid-dependent nephrotic syndrome after rituximab therapy. Pediatr Nephrol (2004) 1.37
In vivo magnetic resonance imaging of dendritic cell migration into the draining lymph nodes of mice. Eur J Immunol (2006) 1.31
Adrenomedullin reduces endothelial hyperpermeability. Circ Res (2002) 1.31
Spinal inflammatory hyperalgesia is mediated by prostaglandin E receptors of the EP2 subtype. J Clin Invest (2005) 1.30
Risk factors associated with adverse drug reactions following hospital admission: a prospective analysis of 907 patients in two German university hospitals. Drug Saf (2008) 1.29
Simultaneous determination of aceclofenac and three of its metabolites in human plasma by high-performance liquid chromatography. Biomed Chromatogr (2003) 1.29
Risk factors associated with adverse drug reactions in hospitalised children: international multicentre study. Eur J Clin Pharmacol (2011) 1.22
Assessment of pediatric asthma drug use in three European countries; a TEDDY study. Eur J Pediatr (2010) 1.19
Identification of ghrelin in human saliva: production by the salivary glands and potential role in proliferation of oral keratinocytes. Clin Chem (2005) 1.15
Role of p-glycoprotein inhibition for drug interactions: evidence from in vitro and pharmacoepidemiological studies. Clin Pharmacokinet (2007) 1.14
Stimulation of GCMa and syncytin via cAMP mediated PKA signaling in human trophoblastic cells under normoxic and hypoxic conditions. FEBS Lett (2005) 1.13
Identification of adverse drug reactions in geriatric inpatients using a computerised drug database. Drugs Aging (2003) 1.12
Epidemiology and potential associated risk factors of drug-related problems in hospitalised children in the United Kingdom and Saudi Arabia. Eur J Clin Pharmacol (2012) 1.11
The Safety of Drug Therapy in Children. Dtsch Arztebl Int (2015) 1.11
A role for endocannabinoids in indomethacin-induced spinal antinociception. Eur J Pharmacol (2002) 1.10
Polymorphisms of TLR4: rapid genotyping and reduced response to lipopolysaccharide of TLR4 mutant alleles. Clin Chem (2002) 1.10
Adverse Drug Reactions in Children--International Surveillance and Evaluation (ADVISE): a multicentre cohort study. Drug Saf (2012) 1.07
Caffeine accelerates absorption and enhances the analgesic effect of acetaminophen. J Clin Pharmacol (2007) 1.07
Analysis of t(9;11) chromosomal breakpoint sequences in childhood acute leukemia: almost identical MLL breakpoints in therapy-related AML after treatment without etoposides. Genes Chromosomes Cancer (2003) 1.06
Analgesic strategies beyond the inhibition of cyclooxygenases. Trends Pharmacol Sci (2006) 1.05
Novel OCRL1 mutations in patients with the phenotype of Dent disease. Am J Kidney Dis (2006) 1.04
Lack of awareness of community-acquired adverse drug reactions upon hospital admission : dimensions and consequences of a dilemma. Drug Saf (2003) 1.03
High frequency oscillatory ventilation suppresses inflammatory response in lung tissue and microdissected alveolar macrophages in surfactant depleted piglets. Pediatr Res (2003) 1.03
The cytotoxic necrotizing factors from Yersinia pseudotuberculosis and from Escherichia coli bind to different cellular receptors but take the same route to the cytosol. Infect Immun (2007) 1.03
Gene expression changes in blood after phlebotomy: implications for gene expression profiling. Blood (2002) 1.02
A complex microdeletion 17q12 phenotype in a patient with recurrent de novo membranous nephropathy. BMC Nephrol (2012) 1.02
Circulating resistin concentrations in children depend on renal function. Nephrol Dial Transplant (2005) 1.00
Sweating ability and genotype in individuals with X-linked hypohidrotic ectodermal dysplasia. J Med Genet (2011) 1.00
Comparison of antiepileptic drug prescribing in children in three European countries. Epilepsia (2009) 0.97
Reduction of neuronal and inducible nitric oxide synthase gene expression in patients with cystic fibrosis. Eur Arch Otorhinolaryngol (2002) 0.97
Altered 24-hour blood pressure profiles in children and adolescents with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab (2006) 0.97
Effect of the CYP2D6 genotype on metoprolol metabolism persists during long-term treatment. Pharmacogenetics (2002) 0.97
Characterization of beta-adrenoceptor antagonists as substrates and inhibitors of the drug transporter P-glycoprotein. Fundam Clin Pharmacol (2006) 0.96
Combining functional magnetic resonance imaging with mouse genomics: new options in pain research. Neuroreport (2010) 0.96
Drug utilisation on a preterm and neonatal intensive care unit in Germany: a prospective, cohort-based analysis. Eur J Clin Pharmacol (2009) 0.96
Off-label medicine use in children and adolescents: results of a population-based study in Germany. BMC Public Health (2013) 0.95
Imaging of hyperalgesia in rats by functional MRI. Eur J Pain (2006) 0.95
Effects of orally applied candesartan cilexetil on central responses to angiotensin II in conscious rats. J Hypertens (2002) 0.95
Rise in antiobesity drug prescribing for children and adolescents in the UK: a population-based study. Br J Clin Pharmacol (2009) 0.95
Dipyrone elicits substantial inhibition of peripheral cyclooxygenases in humans: new insights into the pharmacology of an old analgesic. FASEB J (2007) 0.94
Characterization of monocyte-derived dendritic cells in recent-onset diabetes mellitus type 1. Clin Immunol (2002) 0.94
Stabilization of gene expression profiles in blood after phlebotomy. Clin Chem (2002) 0.94
15-Deoxy-Delta(12,14)-prostaglandin J2 inhibits the expression of proinflammatory genes in human blood monocytes via a PPAR-gamma-independent mechanism. Biochem Biophys Res Commun (2003) 0.94
Are computerised monitoring systems of value to improve pharmacovigilance in paediatric patients? Eur J Clin Pharmacol (2006) 0.94
Celecoxib modulates the expression of cyclooxygenase-2, ki67, apoptosis-related marker, and microvessel density in human cervical cancer: a pilot study. Clin Cancer Res (2003) 0.93
Paracetamol, ibuprofen, or a combination of both drugs against knee pain: an excellent new randomised clinical trial answers old questions and suggests new therapeutic recommendations. Ann Rheum Dis (2011) 0.93
Evaluation of NT-proBNP and high sensitivity C-reactive protein for predicting cardiovascular risk in patients with arthritis taking longterm nonsteroidal antiinflammatory drugs. J Rheumatol (2011) 0.93
Sustained delivery of therapeutic concentrations of human clotting factor IX--a comparison of adenoviral and AAV vectors administered in utero. J Gene Med (2002) 0.93
Successful withdrawal of steroids in pediatric renal transplant recipients receiving cyclosporine A and mycophenolate mofetil treatment: results after four years. Transplantation (2004) 0.92
Regulation of IL-13 synthesis in human lymphocytes: implications for asthma therapy. Br J Pharmacol (2002) 0.92
Childhood obesity: concept, feasibility, and interim results of a local group-based, long-term treatment program. J Nutr Educ Behav (2008) 0.92
Automated, fast and sensitive quantification of 17 alpha-hydroxy-progesterone, androstenedione and testosterone by tandem mass spectrometry with on-line extraction. Steroids (2006) 0.92
Integrating macrophages into organotypic co-cultures: a 3D in vitro model to study tumor-associated macrophages. PLoS One (2012) 0.91
Latanoprost induces matrix metalloproteinase-1 expression in human nonpigmented ciliary epithelial cells through a cyclooxygenase-2-dependent mechanism. FASEB J (2005) 0.91
Synergistic effects of hypoxia and insulin are regulated by different transcriptional elements of the human leptin promoter. Biochem Biophys Res Commun (2003) 0.91
The C terminus of YopT is crucial for activity and the N terminus is crucial for substrate binding. Infect Immun (2003) 0.90
Simultaneous quantification of ghrelin and desacyl-ghrelin by liquid chromatography-tandem mass spectrometry in plasma, serum, and cell supernatants. Clin Chem (2007) 0.89
Celecoxib inhibits metabolism of cytochrome P450 2D6 substrate metoprolol in humans. Clin Pharmacol Ther (2003) 0.88
Simultaneous determination of leflunomide and its active metabolite, A77 1726, in human plasma by high-performance liquid chromatography. Biomed Chromatogr (2003) 0.88
Expression of neuropeptide Y, omentin and visfatin in visceral and subcutaneous adipose tissues in humans: relation to endocrine and clinical parameters. Obes Facts (2010) 0.88
R(+)-methanandamide and other cannabinoids induce the expression of cyclooxygenase-2 and matrix metalloproteinases in human nonpigmented ciliary epithelial cells. J Pharmacol Exp Ther (2005) 0.88
Successful interventional treatment of arteriovenous fistula after kidney biopsy in pediatric patients--a report of three cases. Nephrol Dial Transplant (2008) 0.88
Steady-state free precession projection MRI as a potential alternative to the conventional chest X-ray in pediatric patients with suspected pneumonia. Eur Radiol (2002) 0.87
Kinetics and functional characterization of the glycine receptor alpha2 and alpha3 subunit. Neurosci Lett (2007) 0.87
Drug insight: cyclo-oxygenase-2 inhibitors--a critical appraisal. Nat Clin Pract Rheumatol (2007) 0.87
Up-regulation of cyclooxygenase-2 expression is involved in R(+)-methanandamide-induced apoptotic death of human neuroglioma cells. Mol Pharmacol (2004) 0.87
Normal sensitivity to acute pain, but increased inflammatory hyperalgesia in mice lacking the nociceptin precursor polypeptide or the nociceptin receptor. Eur J Neurosci (2003) 0.87